Activation of transsulfuration pathway by salvianolic acid a treatment: A homocysteine-lowering approach with beneficial effects on redox homeostasis in high-fat diet-induced hyperlipidemic rats

Nutrition and Metabolism

Volumn 10, Issue 1, 2013, Pages

  Zhang, Wenting ^a   He, Hua ^a   Wang, Haidong ^a   Wang, Shijun ^a   Li, Xi ^a   Liu, Yao ^a   Jiang, Huiyong ^a   Jiang, Hao ^a   Yan, Yidan ^a   Wang, Yixuan ^a   Liu, Xiaoquan ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Homocysteine; Hyperlipidemia; Redox status; Salvianolic acid A; Transsulfuration pathway

Indexed keywords

ANTILIPEMIC AGENT; BENZOFURAN DERIVATIVE; CHOLESTEROL; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE SYNTHASE; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; SALVIANOLIC ACID A; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; HOMEOSTASIS; HYPERLIPIDEMIA; HYPOTHESIS; IN VITRO STUDY; LIPID BLOOD LEVEL; LIPID DIET; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LIVER HOMOGENATE; MALE; METABOLITE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; RAT; SULFATION AND DESULFURIZATION; SULFURATION; TRIACYLGLYCEROL BLOOD LEVEL;

RATTUS;

EID: 84889073772     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-10-68     Document Type: Article

References (43)

1. Pharmacotherapy of dyslipidemia. McKenney JM, Cardiovasc Drugs Ther 2001 15 413 422 10.1023/A:1013341606476 11855660 (Pubitemid 34098512)
2. Examination of adhesion molecules, homocysteine and hs-CRP in patients with polygenic hypercholesterolemia and isolated hypertriglyceridemia. Calan M, Calan O, Gonen MS, Bilgir F, Kebapcilar L, Kulac E, Cinali T, Bilgir O, Intern Med 2011 50 1529 1535 10.2169/internalmedicine.50.4297 21804277
3. The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Mosharov E, Cranford MR, Banerjee R, Biochemistry 2000 39 13005 13011 10.1021/bi001088w 11041866
4. Physiology of folate and vitamin B12 in health and disease. Stover PJ, Nutr Rev 2004 62 3 12 discussion S13 15298442
5. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. Armitage JM, Bowman L, Clarke RJ, Wallendszus K, Bulbulia R, Rahimi K, Haynes R, Parish S, Study of the Effectiveness of Additional Reductions in C, Homocysteine Collaborative G, et al. JAMA 2010 303 2486 2494 20571015
6. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. Bazzano LA, Reynolds K, Holder KN, He J, JAMA 2006 296 2720 2726 10.1001/jama.296.22.2720 17164458 (Pubitemid 44917549)
7. Moderate vitamin B-6 restriction does not alter postprandial methionine cycle rates of remethylation, transmethylation, and total transsulfuration but increases the fractional synthesis rate of cystathionine in healthy young men and women. Lamers Y, Coats B, Ralat M, Quinlivan EP, Stacpoole PW, Gregory JF 3rd, J Nutr 2011 141 835 842 10.3945/jn.110.134197 21430249
8. Redox regulation of homocysteine-dependent glutathione synthesis. Vitvitsky V, Mosharov E, Tritt M, Ataullakhanov F, Banerjee R, Redox Rep 2003 8 57 63 10.1179/135100003125001260 12631446 (Pubitemid 36204255)
9. Bcl-2 is a novel interacting partner for the 2-oxoglutarate carrier and a key regulator of mitochondrial glutathione. Wilkins HM, Marquardt K, Lash LH, Linseman DA, Free Radic Biol Med 2012 52 410 419 10.1016/j.freeradbiomed.2011. 10.495 22115789
10. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity Implications for Parkinson's disease. Jha N, Jurma O, Lalli G, Liu Y, Pettus EH, Greenamyre JT, Liu RM, Forman HJ, Andersen JK, J Biol Chem 2000 275 26096 26101 10.1074/jbc.M000120200 10846169
11. Emodin prevents intrahepatic fat accumulation, inflammation and redox status imbalance during diet-induced hepatosteatosis in rats. Alisi A, Pastore A, Ceccarelli S, Panera N, Gnani D, Bruscalupi G, Massimi M, Tozzi G, Piemonte F, Nobili V, Int J Mol Sci 2012 13 2276 2289 10.3390/ijms13022276 22408453
12. Redox regulation of mitochondrial ATP synthase: implications for cardiac resynchronization therapy. Wang SB, Foster DB, Rucker J, O'Rourke B, Kass DA, Van Eyk JE, Circ Res 2011 109 750 757 10.1161/CIRCRESAHA.111.246124 21817160
13. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Mattson MP, Shea TB, Trends Neurosci 2003 26 137 146 10.1016/S0166-2236(03)00032-8 12591216 (Pubitemid 36183675)
14. Effects of red wine polyphenolic compounds on paraoxonase-1 and lectin-like oxidized low-density lipoprotein receptor-1 in hyperhomocysteinemic mice. Noll C, Hamelet J, Matulewicz E, Paul JL, Delabar JM, Janel N, J Nutr Biochem 2009 20 586 596 10.1016/j.jnutbio.2008.06.002 18676137
15. Effects of catechin on homocysteine metabolism in hyperhomocysteinemic mice. Hamelet J, Demuth K, Dairou J, Ledru A, Paul JL, Dupret JM, Delabar JM, Rodrigues-Lima F, Janel N, Biochem Biophys Res Commun 2007 355 221 227 10.1016/j.bbrc.2007.01.142 17292331 (Pubitemid 46273391)
16. Cardioprotective effect of salvianolic acid A on isoproterenol-induced myocardial infarction in rats. Wang SB, Tian S, Yang F, Yang HG, Yang XY, Du GH, Eur J Pharmacol 2009 615 125 132 10.1016/j.ejphar.2009.04.061 19445921
17. Effect of salvianolic acid A on vascular reactivity of streptozotocin-induced diabetic rats. Wang SB, Yang XY, Tian S, Yang HG, Du GH, Life Sci 2009 85 499 504 10.1016/j.lfs.2009.07.018 19695266
18. Salvianolic acid A protects against vascular endothelial dysfunction in high-fat diet fed and streptozotocin-induced diabetic rats. Yang XY, Qiang GF, Zhang L, Zhu XM, Wang SB, Sun L, Yang HG, Du GH, J Asian Nat Prod Res 2011 13 884 894 10.1080/10286020.2011.598457 21972802
19. Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes. Liu GT, Zhang TM, Wang BE, Wang YW, Biochem Pharmacol 1992 43 147 152 10.1016/0006-2952(92)90271-J 1739402
20. Beneficial effects of danshensu, an active component of Salvia miltiorrhiza, on homocysteine metabolism via the trans-sulphuration pathway in rats. Cao Y, Chai JG, Chen YC, Zhao J, Zhou J, Shao JP, Ma C, Liu XD, Liu XQ, Br J Pharmacol 2009 157 482 490 10.1111/j.1476-5381.2009.00179.x 19422396
21. Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting. Pfeiffer CM, Huff DL, Gunter EW, Clin Chem 1999 45 290 292 9931056 (Pubitemid 29079132)
22. Isocratic high performance liquid chromatographic analysis of S-adenosylmethionine and S-adenosylhomocysteine in animal tissues: the effect of exposure to nitrous oxide. Bottiglieri T, Biomed Chromatogr 1990 4 239 241 10.1002/bmc.1130040606 2289047
23. Measurement of protein using bicinchoninic acid. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC, Anal Biochem 1985 150 76 85 10.1016/0003-2697(85)90442-7 3843705 (Pubitemid 16258399)
24. Folate-deficiency-induced homocysteinaemia in rats: disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism. Miller JW, Nadeau MR, Smith J, Smith D, Selhub J, Biochem J 1994 298 Pt 2 415 419 8135750 (Pubitemid 24072486)
25. Tumor necrosis factor-alpha-induced targeted proteolysis of cystathionine beta-synthase modulates redox homeostasis. Zou CG, Banerjee R, J Biol Chem 2003 278 16802 16808 10.1074/jbc.M212376200 12615917 (Pubitemid 36799549)
26. Effects of chronic ethanol feeding on glutathione turnover in the rat. Morton S, Mitchell MC, Biochem Pharmacol 1985 34 1559 1563 10.1016/0006-2952(85) 90699-9 2859860 (Pubitemid 15025797)
27. A crystalline enzyme that cleaves homoserine and cystathionine. I. Isolation procedure and some physicochemical properties. Matsuo Y, Greenberg DM, J Biol Chem 1958 230 545 560 13525371
28. H2S biogenesis by human cystathionine gamma-lyase leads to the novel sulfur metabolites lanthionine and homolanthionine and is responsive to the grade of hyperhomocysteinemia. Chiku T, Padovani D, Zhu W, Singh S, Vitvitsky V, Banerjee R, J Biol Chem 2009 284 11601 11612 19261609
29. Fluvastatin alters platelet aggregability in patients with hypercholesterolemia: possible improvement of intraplatelet redox imbalance via HMG-CoA reductase. Haramaki N, Ikeda H, Takenaka K, Katoh A, Sugano R, Yamagishi S, Matsuoka H, Imaizumi T, Arterioscler Thromb Vasc Biol 2007 27 1471 1477 10.1161/ATVBAHA.106.128793 17379842 (Pubitemid 46809440)
30. Physiological model for tissue glutathione depletion and increased resynthesis after ethylene dichloride exposure. D'Souza RW, Francis WR, Andersen ME, J Pharmacol Exp Ther 1988 245 563 568 3367306
31. Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. Zhang D, Xie X, Chen Y, Hammock BD, Kong W, Zhu Y, Circ Res 2012 110 808 817 10.1161/CIRCRESAHA.111.259325 22354938
32. Effect of cysteine dosage on erythrocyte glutathione synthesis rate in a patient with cystathionine beta synthase deficiency. Van der Crabben SN, Wijburg FA, Ackermans MT, Sauerwein HP, J Inherit Metab Dis 2008 Epub ahead of print
33. High fat diet-induced non alcoholic fatty liver disease in rats is associated with hyperhomocysteinemia caused by down regulation of the transsulphuration pathway. Bravo E, Palleschi S, Aspichueta P, Buque X, Rossi B, Cano A, Napolitano M, Ochoa B, Botham KM, Lipids Health Dis 2011 10 60 10.1186/1476-511X-10-60 21504583
34. Apoptosis vs. necrosis: glutathione-mediated cell death during rewarming of rat hepatocytes. Vairetti M, Ferrigno A, Bertone R, Richelmi P, Berte F, Freitas I, Biochim Biophys Acta 2005 1740 367 374 10.1016/j.bbadis.2004.11.022 15949704 (Pubitemid 40804749)
35. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Griffith OW, Free Radic Biol Med 1999 27 922 935 10.1016/S0891-5849(99)00176-8 10569625 (Pubitemid 29507466)
36. Impaired synthesis contributes to diabetes-induced decrease in liver glutathione. Furfaro AL, Nitti M, Marengo B, Domenicotti C, Cottalasso D, Marinari UM, Pronzato MA, Traverso N, Int J Mol Med 2012 29 899 905 22344537
37. Sclerotinia sclerotiorum gamma-glutamyl transpeptidase (Ss-Ggt1) is required for regulating glutathione accumulation and development of sclerotia and compound appressoria. Li M, Liang X, Rollins JA, Mol Plant Microbe Interact 2012 25 412 420 10.1094/MPMI-06-11-0159 22046959
38. Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism. James SJ, Rose S, Melnyk S, Jernigan S, Blossom S, Pavliv O, Gaylor DW, FASEB J 2009 23 2374 2383 10.1096/fj.08-128926 19307255
39. Rat cystathionine beta-synthase: expression of four alternatively spliced isoforms in transfected cultured cells. Roper MD, Kraus JP, Arch Biochem Biophys 1992 298 514 521 10.1016/0003-9861(92)90443-Z 1384433
40. Effects of salvianolic acid a on oxidative stress and liver injury induced by carbon tetrachloride in rats. Wu ZM, Wen T, Tan YF, Liu Y, Ren F, Wu H, Basic Clin Pharmacol Toxicol 2007 100 115 120 10.1111/j.1742-7835.2007.00020. x 17244260 (Pubitemid 46146715)
41. Effects of salvianolic acids on oxidative stress and hepatic fibrosis in rats. Tsai MK, Lin YL, Huang YT, Toxicol Appl Pharmacol 2010 242 155 164 10.1016/j.taap.2009.10.002 19822164
42. Oxidative stress as a mediator of cardiovascular disease. Elahi MM, Kong YX, Matata BM, Oxid Med Cell Longev 2009 2 259 269 10.4161/oxim.2.5.9441 20716913
43. Antiplatelet and antithrombotic activities of salvianolic acid A. Fan HY, Fu FH, Yang MY, Xu H, Zhang AH, Liu K, Thromb Res 2010 126 17 22 10.1016/j.thromres.2010.04.006 20451955